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ABSTRACT
Background Hyperpolarised 3He MRI provides a way
to visualise regional pulmonary functional abnormalities
that in asthma are thought to be related to airway
morphological abnormalities. However, the exact
aetiology of ventilation defects in asthma is not well
understood.
Objective To better understand the determinants of
ventilation defects in asthma, we evaluated well-
established clinical as well as 3He MRI and X-ray CT
airway measurements in healthy subjects and subjects
with asthma.
Methods Thirty-four subjects (n=26 subjects with
asthma, n=8 healthy volunteers) underwent MRI,
spirometry, plethysmography, fraction of exhaled nitric
oxide analysis, methacholine challenge and CT for a
region-of-interest proximal to ventilation defects. For
subjects who consented to CT (n=18 subjects with
asthma, n=5 healthy volunteers), we evaluated 3rd to
5th generation airway wall area and wall thickness per
cent and lumen area.
Results Seventeen subjects with asthma (17/26=65%)
had visually obvious evidence of 3He ventilation defects
prior to bronchoprovocation and nine subjects with
asthma had no ventilation defects prior to
bronchoprovocation (9/26=35%). Subjects with asthma
with defects were older (p=0.01) with worse forced
expiratory volume in 1 s (FEV1)/forced vital capacity
(p=0.0003), airways resistance (p=0.004), fraction of
exhaled nitric oxide (p=0.03), greater
bronchoprovocation concentration of methacholine that
reduced FEV1 by 20% (p=0.008) and wall thickness per
cent (p=0.02) compared with subjects with asthma
without defects. There was a moderate correlation for
wall area per cent with ventilation defect per cent
(r=0.43, p=0.04).
Conclusions Subjects with asthma with 3He ventilation
defects were older with significantly worse airway hyper-
responsiveness, inflammation and airway remodelling but
similar FEV1 as subjects with asthma without defects;
hyperpolarised 3He ventilation abnormalities were
spatially and quantitatively related to abnormally
remodelled airways.
INTRODUCTION
Asthma is typically diagnosed and characterised
using the spirometry measurement1 2 of the forced
expiratory volume in 1 s (FEV1). Although relatively
simple and inexpensive, spirometry measurements
provide a global estimate of the morphological
changes in the small and medium-sized airways that
are believed to be related to luminal inflammation,
airway remodelling and constriction. We now realise
using multiple breath nitrogen washout studies3 4
and pulmonary imaging methods, that functional
abnormalities in asthma are in fact regionally hetero-
geneous,5–7 temporally persistent8–10 and that these
abnormalities regionally respond to bronchoprovo-
cation7 11 12 and to bronchodilator therapy.11 13
Key messages
What is the key question?
▸ In asthma, functional MRI using hyperpolarised
3He gas has been used to visualise abnormal
and heterogeneous inhaled gas distribution.
Regions of signal void or ventilation defects,
are believed to correspond to areas of the lung
that are not ventilated and such defects have
been shown to change in response to
bronchoprovocation and bronchodilators.
Notwithstanding this previous work, our current
understanding of the aetiology and clinical
meaning of ventilation defects in asthma is still
very limited.
What is the bottom line?
▸ MRI and X-ray CT measurements of airway
morphology and function were prospectively
evaluated for healthy volunteers and subjects
with asthma with and without ventilation
defects. Seventeen subjects with asthma (17/
26=65%) had visually obvious 3He ventilation
defects; these subjects were significantly older,
had significantly worse forced expiratory
volume in 1 s/forced vital capacity, airways
resistance, fraction of exhaled nitric oxide, and
airway hyper-responsiveness, as well as more
thickened airway walls and more narrowed
airway lumen compared with nine subjects
with asthma without ventilation defects.
Why read on?
▸ We report the quantitative and spatial
relationship between ventilation defects with
remodelled airways and with well-established
measurements of asthma severity, and that
subjects with asthma with ventilation defects
were older and had more advanced or severe
disease. Taken together, these findings provide
us with a better understanding of the
differences between subjects with asthma with
similar FEV1 and the clinical meaning of
ventilation defects in asthma.
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Thoracic X-ray CT has been used for over a decade as a non-
invasive method to investigate structure-function relationships of
asthmatic airways and has shown strong relationships between
CT-derived airway measurements with inflammation,14 15 spir-
ometry14–21 and disease severity.14 16 20 22 However, while these
CT data are encouraging, they are still somewhat limited because
it is well recognised that CT cannot resolve or measure airways
beyond the fifth or sixth generation. Moreover, even using new
lower dose and iterative reconstruction methods,23 CT is not
recommended for longitudinal studies and studies of young
adults and children because of the potential risks associated with
exposure to ionising radiation. Other pulmonary imaging
methods such as nuclear medicine scintigraphy24–26 and positron
emission tomography27 are also limited clinically because of
inherently low spatial resolution.
Hyperpolarised 3He MRI has been previously used to visualise
heterogeneous and abnormal gas distribution in asthma. Regions
of signal void or ventilation defects have been shown to be tem-
porally persistent8–10 and to correlate significantly with spirom-
etry,6 28 29 disease severity6 and CT measurements of gas
trapping.28 In addition, 3He MRI also provides a way to perform
intensive serial measurements due in part to its excellent safety
profile,30 and the speed with which imaging can be performed.
More specifically, 3He MRI ventilation defects have been shown to
increase from baseline following methacholine7 11 12 and exer-
cise12 challenge, and decrease from baseline following salbutamol
administration.13 In asthma, the relationship between ventilation
defects and patient outcomes such as exacerbation frequency and
severity has not yet been evaluated; however this has been evalu-
ated in chronic obstructive pulmonary disease.31 Recently, there
has been growing interest in the clinical application of hyperpo-
larised gas MRI to assess treatment efficacy and furthermore to
guide localised airway treatments in asthma. Preliminary work in
severe asthma has shown improved 3He gas distribution following
localised bronchial thermoplasty treatment.32 While these results
provide a strong foundation for the use of MRI in asthma research
and patient care, a major drawback has been that we do not clearly
understand the aetiology of MRI ventilation defects.33 It has been
speculated that MRI ventilation defects reflect regional airway nar-
rowing that may be the consequence of airway remodelling34;
however, to our knowledge, the direct spatial and quantitative rela-
tionship between MRI ventilation defects and CTairway measure-
ments has not been reported in patients with asthma. Therefore,
our objective was to determine the underlying structural and clin-
ical determinants of asthma ventilation abnormalities by evaluating
well-established clinical and emerging imaging (hyperpolarised
3He MRI and CT) measurements in healthy volunteers and sub-
jects with asthma.
METHODS
Study subjects
All subjects provided written informed consent to a study protocol
approved by the local research ethics board, and the study was
compliant with the Personal Information Protection and Electronic
Documents Act (Canada) and the Health Insurance Portability and
Accountability Act (USA). Subjects were enrolled between 18 years
and 60 years of age, including mild-to-moderate35 subjects with
asthma, and healthy subjects with no history or diagnosis of asthma
or any other chronic or current acute respiratory illness. Subjects
with asthma were phenotyped from health records based on
disease severity and symptoms from a tertiary care centre (interdis-
ciplinary Allergy and Respirology asthma care centre); all subjects
with asthma had a current physician diagnosis of asthma, were cur-
rently under treatment for asthma and had a positive methacholine
challenge within the past 5 years. At a single visit, spirometry,
plethysmography, fractional exhaled nitric oxide (FeNO) breath
analysis and pulmonary CTwas performed within 30 min of MRI.
Pulmonary function tests
Spirometry and plethysmography were performed according to
American Thoracic Society Guidelines36 using an ndd EasyOne
spirometer (ndd Medizintechnik AG, Zurich, Switzerland) and a
MedGraphics Elite Series plethysmograph (MedGraphics, St
Paul, Minnesota, USA), respectively. FeNO was measured using
a Niox Mino (Aerocrine USA, New Providence, New Jersey,
USA). Methacholine challenge was performed as previously
described11 and the provocative concentration causing a 20%
decrease in FEV1 (PC20) was determined. Borg and modified
Medical Research Council dyspnoea scores were recorded.
MRI
MRI was performed on a whole body 3.0 T Discovery 750MR
(General Electric Health Care, Milwaukee, Wisconsin, USA)
system with broadband imaging capability, as previously
described.37 Subjects were instructed to inhale a gas mixture
from a 1.0 L Tedlar bag ( Jensen Inert Products, Coral Springs,
Florida, USA) from functional residual capacity, and image
acquisition was performed in 8–15 s under breath-hold condi-
tions. Conventional 1H MRI was performed prior to hyperpo-
larised 3He MRI, both methods are previously described.37
3He MRI were qualitatively and quantitatively evaluated for
ventilation abnormalities by a single trained observer. Upon
qualitative inspection, subjects with asthma were classified into
two groups, (1) subjects with asthma with no ventilation defects
(ND) and (2) subjects with asthma with ventilation defects (AD).
If 3He gas was homogenously distributed throughout the lung
and there were no visible ventilation defects the subject was clas-
sified as belonging to the ND group. In contrast, if 3He gas was
heterogeneously distributed throughout the lung and/or there
were visually obvious ventilation defects, the subject was classi-
fied as belonging to the AD group. Quantitative evaluation of
3He MRI was performed to estimate ventilation defect per cent
(VDP) and ventilation heterogeneity using the coefficient of vari-
ation (COV). 3He MRI semiautomated segmentation was per-
formed to quantify lung volumes using custom software
generated using MATLAB R2007b (The Mathworks, Natick,
Massachusetts, USA), as previously described.38 As shown in
figure 1, 3He static ventilation images were segmented using a
K-means approach that classified voxel intensity values into five
clusters ranging from signal void (cluster 1 (C1) or ventilation
defect volume) to hyperintense signal (cluster 5 (C5)) to create a
gas distribution cluster map. 3He MRI VDP was generated using
ventilation defect volume normalised to the thoracic cavity
volume. Whole lung and regional VDP specific to the CT
region-of-interest (ROI) were generated for each subject.
Ventilation heterogeneity was estimated according to previously
described methods7 using the COV. Briefly, a ventilated lung ROI
was defined as gas distribution cluster-map clusters C2–C5. For
each voxel within the ventilated lung ROI a local ventilation het-
erogeneity value was calculated by computing the COV of the
signal intensity in the voxels 5×5 neighbourhood. Mean COV
for each slice was calculated for each 3He static ventilation slice
and then averaged to obtain a single COV value for each subject.
CT
Following 3He MRI, thoracic CTwas performed with the same
inhalation breath-hold volume and manoeuvre used for MRI, in
order to match CT and MRI lung volume and anatomy. CT
64 Svenningsen S, et al. Thorax 2014;69:63–71. doi:10.1136/thoraxjnl-2013-203711
Respiratory research
Acquisitions Unit. Protected by copyright.
 o
n
 M
arch 3, 2020 at Univ O
f W
est O
ntario G
STR101749364 Serials
http://thorax.bmj.com/
Thorax: first published as 10.1136/thoraxjnl-2013-203711 on 16 August 2013. Downloaded from 
imaging was performed in the supine position using a 64-slice
Lightspeed VCT scanner (GEHC, Milwaukee, Wisconsin, USA)
using a detector configuration of 64×0.625 mm, 120 kVp,
100 mA, 0.5 s gantry rotation, and a pitch of 1.25. To reduce
the radiation dose, CTwas obtained for a 4 cm axial ROI where
there were visually obvious MRI ventilation defects. In the case
where there were no visually obvious ventilation defects, the CT
volume was acquired in the superior region of the lung. This
approach resulted in CT volumes consisting of 32–80 slices and
a total effective dose ranging from 0.37 to 0.14 m Sv (generated
using the CT parameters and algorithm at http://www.
impactscan.org).
CT image analysis was performed using Pulmonary
Workstation V.2.0, (VIDA Diagnostics; Iowa City, Iowa, USA) to
Figure 1 Schematic for 3He MRI—Regional CT image acquisition, coregistration and analysis. A region-of-interest (ROI) (green-yellow rectangle)
with ventilation defects was located using 3He MRI. Following MRI, regional CT was acquired in that specific ROI. Ventilation defect per cent (VDP)
was quantified for the whole lung and the CT-derived ROI and an automated airway tree segmentation algorithm was applied to obtain airway
measurements. Using the carina and trachea as a landmark, the regional CT with rendered airways was rigidly coregistered with the corresponding
MRI to confirm the spatial relationship between ventilation defects and corresponding airways.
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generate bronchial wall area per cent, wall thickness per cent
and lumen area for all 3rd–5th generation segmental bronchi
analysed and lumen area was normalised to body surface area.39
As shown in figure 1, an automated airway tree segmentation
algorithm was applied with a manual seed-point in the airway
lumen introduced if the trachea and main bronchus were not
present in the image. For each subject, all airway segment mea-
surements were averaged to report whole lung means. To iden-
tify potential spatial relationships between 3He MRI ventilation
defects and corresponding airways, CT-MRI coregistration was
performed using 3D Slicer registration software (http://www.
slicer.org). 40
Statistical methods
Pulmonary function tests, MRI and CT measurements were
compared between subject groups using unpaired Student t tests
performed using SPSS V.20.0 (IBM, Armonk, New York, USA).
Linear regression (r2) and Spearman rank correlation coefficients
(r) were performed using GraphPad Prism V.4.00 (Graphpad
Software, San Diego, California, USA). Results were considered
statistically significant when the probability of making a Type I
error was less than 5% (p<0.05).
RESULTS
We enrolled 34 subjects including 26 subjects with a clinical
diagnosis of asthma and previous methacholine challenge results
consistent with asthma, and 8 healthy volunteers. Table 1 shows
subject demographic data, pulmonary function measurements
and dyspnoea scores for the two subgroups, and a subject listing
of all data is provided in the online supplementary table S1.
Upon qualitative visual inspection, 9 of the 26 subjects with
asthma had ND and 17 had visually obvious AD. Figure 2
shows posterior, centre and anterior 3He MRI static ventilation
coronal slices (in blue) coregistered to the 1H anatomical MRI
(in grey scale) for a representative healthy volunteer as well as
ND and AD subjects with asthma with yellow arrows identifying
ventilation defects. For healthy volunteers and ND subjects with
asthma, 3He gas was homogeneously distributed throughout the
lung whereas in contrast, AD subjects with asthma had visually
obvious ventilation heterogeneity and ventilation defects. Of the
8 healthy volunteers and 26 subjects with asthma evaluated, 2
healthy volunteers and 12 subjects with asthma underwent
imaging across multiple time points ranging from 4 years prior,
to 2 years following the study session reported here. In accord-
ance with the study visit data presented here, healthy volunteers
had NDs at their additional time point. All subjects with asthma
who underwent multiple imaging time points were AD subjects
with asthma and all of these subjects had ventilation defects at
their additional time point and in the same spatial locations.
Moreover, for all subjects with asthma with repeated imaging
measurements (n=12), VDP was not significantly different
(p=0.49) from measurements acquired and reported in this
study.
As shown in table 2, AD subjects were significantly older than
ND subjects (p=0.01) with significantly worse FEV1/forced
vital capacity (FVC) (p=0.0003), specific airways resistance
(sRaw) (p=0.004), FeNO (p=0.03), PC20 (p=0.008), COV
(p=0.046), wall thickness per cent (p=0.02) and lumen area
normalised to body surface area (p=0.04), but importantly
there was no mean difference for FEV1 (p=0.08), FVC
(p=0.71) or dyspnoea (modified Medical Research Council:
p=0.79, Borg: p=0.12). As compared with healthy subjects, AD
subjects had significantly worse FEV1 (p=0.001), FEV1/FVC
(p=0.003), sRaw (p=0.003), PC20 (p<0.0001), COV
(p=0.007), wall area per cent (p=0.001), wall thickness per
cent (p=0.04) and lumen area normalised to body surface area
(p=0.0003), but there was no significant difference for FVC
(p=0.06). ND subjects had significantly worse FVC (p=0.04),
PC20 (p=0.02) and wall area per cent (0.03) compared with
healthy volunteers, but no significant difference for FEV1
(p=0.09), FEV1/FVC (p=0.36), sRaw (p=0.36), COV
(p=0.11), wall thickness per cent (p=0.61) or lumen area nor-
malised to body surface area (p=0.26).
Figure 3 shows the correlations for FEV1 and sRaw with
whole lung VDP, regional VDP and wall area per cent. FEV1
was significantly correlated with 3He MRI VDP (whole lung:
r=−0.61, p=0.0002; regional: r=−0.55, p=0.006) and wall
area per cent (r=−0.49, p=0.02). In addition, sRaw was signifi-
cantly correlated with 3He MRI VDP (whole lung: r=0.77,
p<0.0001; regional: r=0.81, p<0.0001) and wall area per cent
(r=0.48, p=0.02). Additionally, FEV1 and sRaw were signifi-
cantly correlated with whole lung 3He MRI COV (FEV1: r=
−0.49, p=0.003; sRaw: r=0.59, p=0.0003). Figure 4 demon-
strates that for all subjects wall area per cent was significantly
correlated with whole lung (r=0.42, p=0.046) and regional
VDP (r=0.43, p=0.04).
Figure 5 shows hyperpolarised 3He MRI ventilation maps for
four subjects with asthma with the 3He MRI ventilation map in
blue coregistered to the CT volume with the airway tree seg-
mented in yellow. The qualitative spatial relationship between
ventilation defects (yellow arrows) and remodelled airways
(white arrows) is shown.
DISCUSSION
To better understand the structural and clinical determinants of
MRI ventilation defects in asthma, and, in turn, what it might
mean for a subject with asthma to have ventilation defects, we
evaluated well-established clinical measurements and emerging
CT and 3He MRI measurements of airway structure and
function.
We think that it is interesting that 9/26 (35%) subjects with
clinical findings and methacholine challenge results diagnostic of
asthma had a 3He MRI gas distribution that was qualitatively
Table 1 Subject demographic characteristics for subjects with
asthma and healthy volunteers
Healthy (n=8) Subjects with asthma (n=26)
Subject demographics
Age years (±SD) 34 (11) 35 (11)
Male/Female 4/4 12/14
BMI kg/m2 (±SD) 23 (3) 25 (5)
Pulmonary function tests
FEV1%pred (±SD) 102 (10) 84 (15)
FVC %pred (±SD) 103 (10) 93 (11)
FEV1/FVC % (±SD) 81 (6) 74 (11)
sRaw cmH2O·s (±SD) 3.0 (0.5) 6.9 (4.7)
FeNO ppb (±SD) 18* 44 (45)
PC20 mg/mL (±SD) 42.3 (19.2) 5.9 (12.3)
Dyspnoea scores
mMRC score (±SD) 0 (0) 1 (1)
Borg score (±SD) 0 (0) 0.5 (1)
*n=1.
%pred, per cent predicted; BMI, body mass index; FeNO, fraction of exhaled nitric
oxide; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; mMRC,
modified Medical Research Council; PC20, provocative concentration of methacholine
sufficient to induce a 20% decrease in FEV1; sRaw, specific airways resistance.
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and quantitatively (VDP and COV) similar to healthy volunteers.
It is important to note that all of the healthy volunteers had a
homogenous gas distribution with no visual or quantitative evi-
dence of ventilation defects, which is in agreement with previ-
ous work at our centre11 41–43 and others.5 7 44 In contrast, and
as expected based on previous investigations,5–9 11 12 the
remaining 17/26 (65%) subjects with asthma had obvious venti-
lation abnormalities. This observation prompted us to ask the
question: Are subjects with asthma with ventilation defects dif-
ferent from subjects with asthma without ventilation defects?
The results here suggest that subjects with asthma with
ventilation defects are older, with worse FEV1/FVC, (but similar
FEV1), and greater airways resistance, airway responsiveness and
airway inflammation/remodelling. Such findings suggest that
ventilation defects may reflect long-term or progressive airway
remodelling in patients with a longer history of disease or
perhaps more severe or advanced disease. Regardless, the con-
stellation of clinical and imaging findings in these subjects with
asthma suggests that more aggressive therapy or compliance to
therapy is required. This is a hypothesis that can be tested in
future imaging studies of older subjects and/or subjects with
more severe asthma.
Figure 2 Hyperpolarised 3He MRI of a representative healthy volunteer and subjects with asthma. 3He MRI gas distribution (in blue) registered to
the 1H MRI of the thorax (in grey scale) for posterior, centre and anterior coronal slices for a representative healthy volunteer, a subject with asthma
with no ventilation defects, and two subjects with asthma with ventilation defects. Yellow arrows identify ventilation defects. Healthy volunteer:
27 year-old woman, forced expiratory volume in 1 s (FEV1)=105%pred, FEV1/forced vital capacity (FVC)=85%, specific airways resistance (sRaw)
=2.60 cmH2O s. Subject with asthma 1 No Defects: 23 year-old woman, FEV1=82%pred, FEV1/FVC=79%, sRaw=3.80 cmH2O s. Subject with asthma
2 Defects: 25 year-old woman, FEV1=87%pred, FEV1/FVC=69%, sRaw=5.36 cmH2O s. Subject with asthma 3 Defects: 42 year-old man,
FEV1=72%pred, FEV1/FVC=65%, sRaw=13.85 cmH2O s.
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A number of studies have quantitatively investigated asthma
airway structure using CT and showed that bronchial wall thick-
ness was related to asthma severity, duration of disease and
airflow obstruction.14–22 Similarly, 3He MRI has previously
shown that ventilation defects were related to asthma severity6
and in a preliminary report,45 half of a small group of subjects
with asthma (7/15) showed no obvious ventilation defects, with
significantly different bronchial wall thickness (but not bronchial
wall area) compared with subjects with asthma with ventilation
defects. Here, we prospectively acquired MRI and CT within
about 30 min using the same lung volume and breath-hold man-
oeuvre to try to mimic the same airway and parenchyma dimen-
sions using both imaging methods. We must consider that
because 3He gas is itself, highly diffusive and may penetrate
even narrowed airways, there is the possibility that even when
bronchial wall thickness and lumen area are abnormal, some
3He gas ventilation is possible. In support of this explanation,
we note the recent report of indirect or collateral ventilation in
chronic obstructive pulmonary disease that was directly visua-
lised using hyperpolarised 3He MRI46—likely possible only
because the timeframe for imaging was relatively long and 3He
gas is highly diffusive.
We also observed that regional CT airway morphology and
3He ventilation defect measurements were significantly corre-
lated. This important finding suggests that there is a relationship
between airways that are remodelled and/or constricted and ven-
tilation defects. Previous studies have demonstrated that focal
regions of hyperlucency on CT (likely related to gas trapping)
were spatially correlated with 3He MRI ventilation defects28
and bronchoalveolar lavage had higher total and per cent neu-
trophils in areas of the lung with greater ventilation defects, sug-
gestive of increased inflammation. Although we observed
significant relationships between airway dimensions and defects,
these relationships were modest, perhaps because of the hetero-
geneity of asthma and the patients with asthma evaluated here,
or because of the relatively low dose partial CT ROI that was
used. It is important to acknowledge that in asthma, the airways
from the large bronchi to the alveolar ducts may be involved,47
thus using CT to measure airway dimensions has limitations
because CT cannot spatially resolve the small airways (<2 mm)
sufficiently to provide accurate measurements. In addition to
small and heterogeneously distributed ventilation defects, some
of the subjects with asthma evaluated here presented large
wedge-shaped defects; these have previously been reported
using single photon emission CT imaging with Technegas25 and
are believed to be the result of subsegmental airway narrowing.
Following MRI-CT registration we were able to identify and
quantify subsegmental bronchi that were spatially related to ven-
tilation defects. Larger ‘subsegmental’ ventilation defects may be
the result of proximal remodelled subsegmental airways feeding
these regions of signal void. Unfortunately, due to the limita-
tions of the spatial resolution of the CT images, we cannot
comment on the structure of the smaller airways distal to the
subsegmental airways quantified here, which may further con-
tribute to the abnormal gas distributions observed.
Large and temporally persistent 3He ventilation defects
provide excellent targets for therapy and could potentially guide
localised airway treatments such as bronchial thermoplasty.
Table 2 Subject demographic characteristics, pulmonary function, hyperpolarised 3He MRI and X-ray CT airways measurements for subjects
with asthma and healthy volunteers
Healthy (n=8) Asthma (n=26) Significance of difference* (p value)
ND (n=9) AD (n=17) HV vs ND HV vs AD ND vs AD
Subject demographics
Age years (±SD) 34 (11) 27 (8) 39 (11) 0.19 0.29 0.01
Male/Female 4/4 2/7 10/7 – – –
Pulmonary function tests
FEV1%pred (±SD) 102 (10) 91 (13) 81 (14) 0.09 0.001 0.08
FVC %pred (±SD) 103 (10) 92 (10) 94 (11) 0.04 0.06 0.71
FEV1/FVC % (±SD) 81 (6) 84 (7) 69 (10) 0.36 0.003 0.0003
sRaw cmH2O·s (±SD) 2.96 (0.53) 3.42 (1.22) 8.51 (4.95) 0.36 0.003 0.004
FeNO ppb (±SD) 18† 17 (9)‡ 60 (50)§ – – 0.03
PC20 mg/mL (±SD) 42.3 (19.2) 14.3 (16.8) 1.4 (3.9) 0.02 <0.0001 0.008
Dyspnoea
mMRC score (±SD) 0.0 (0.0) 0.7 (0.7) 0.8 (1.0) 0.02 0.04 0.79
Borg score (±SD) 0.1 (0.2) 0.2 (0.3) 0.7 (0.8) 0.28 0.047 0.12
3He MRI
Whole lung VDP% (±SD) 1.22 (0.19) 1.31 (0.32) 4.26 (3.28) – – –
Regional VDP% (±SD)¶ 0.94 (0.28) 0.95 (0.40) 2.35 (0.98) – – –
Whole lung COV (±SD) 0.22 (0.02) 0.23 (0.01) 0.26 (0.03) 0.11 0.007 0.046
Regional CT¶
WA% (±SD) 62 (2) 66 (3) 69 (3) 0.03 0.001 0.08
WT% (±SD) 24 (4) 25 (2) 29 (4) 0.61 0.04 0.02
LA mm2 (±SD) 18 (3) 14 (6) 11 (4) 0.19 0.002 0.12
LA/BSA mm2/m2 (±SD) 10 (2) 8 (3) 6 (2) 0.26 0.0003 0.04
*Significance of difference (p<0.05) determined using a t test.
All statistically significant p values are bold.
†n=1; ‡n=8; §n=13; ¶HV: n=5; ND: n=9; AD: n=9.
%pred, per cent predicted; AD, subjects with asthma with ventilation defects; BSA, body surface area; COV, coefficient of variation; FeNO, fraction of exhaled nitric oxide; FEV1, forced
expiratory volume in 1 s; FVC, forced vital capacity; HV, healthy volunteers; LA, lumen area; mMRC, modified Medical Research Council; ND, subjects with asthma with no ventilation
defects; PC20, provocative concentration of methacholine sufficient to induce a 20% decrease in FEV1; sRaw, specific airways resistance; VDP, ventilation defect per cent; WA%, wall
area per cent; WT%, wall thickness per cent.
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Although we have focused our attention on ventilation defects,
areas of hyperintense signal intensity are often observed in sub-
jects with asthma in conjunction with ventilation defects.
Similar to regions of signal void, to our knowledge, the under-
lying aetiology of these regions has not been investigated. We
hypothesise that hyperintense signal may be due to hyperinfla-
tion and note that investigation of these regions is warranted in
asthma.
We recognise and acknowledge that this work was limited by
the relatively small number of subjects evaluated, although we
note that this is the single largest prospective study that directly
compared CT and 3He MRI in subjects with asthma and healthy
subjects. Furthermore, the subjects evaluated here were enrolled
from a multidisciplinary asthma care centre and therefore they
represent a diverse group of subjects with asthma that have been
mainly referred to improve asthma symptoms and control. As
shown in figure 3, there was a single subject with elevated VDP
as compared with the other AD subjects and we confirmed that
this 42 year-old man had experienced an asthma exacerbation
that required hospitalisation approximately 5 months prior to
hyperpolarised 3He MRI performed here. This subject’s asthma
was previously well controlled and the exacerbation was deter-
mined to be the result of sudden cessation of asthma medica-
tion. It is important to note that the relationships presented in
Figure 4 Relationship between 3He MRI ventilation defect per cent
(VDP) and CT-derived wall area per cent (WA%). WA% was
significantly correlated with whole lung 3He MRI VDP (r=0.42, r2=0.11,
p=0.046) and regional 3He MRI VDP (r=0.43, r2=0.15, p=.04). Dotted
lines represent the 95% CIs of the regression line.
Figure 3 Relationships of MRI and CT measurements with forced expiratory volume in 1 s (FEV1) and airways resistance. (A) Negative relationship
between 3He MRI ventilation defect per cent (VDP) and FEV1%pred (whole lung (WL): r=−0.61, r2=0.20, p=0.0002; regional (RG): r=−0.55, r2=0.26,
p=0.006). (B) Positive relationship between 3He MRI VDP and specific airways resistance (sRaw) (WL: r=0.77, r2=0.62, p<0.0001; RG: r=0.81,
r2=0.75, p<0.0001). (C) Negative relationship between wall area per cent (WA%) and FEV1%pred (r=−0.49, r2=0.23, p=0.02). (D) Positive
relationship between WA% and specific airways resistance (sRaw) (r=0.48, r2=0.21, p=0.02).
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figure 3 remain statistically significant when this outlier is
removed from the analysis. Certainly, this is a hypothesis-
generating study and therefore marginally significant p values
should be interpreted with caution, and larger studies are
required for more extensive phenotyping and characterisation of
subjects with asthma and to test the hypotheses generated here.
We must also acknowledge that our analysis was limited because
of the acquisition of partial CT thoracic volumes.
In summary, our results showed that subjects with asthma
with 3He MRI ventilation abnormalities were older, with
greater airway hyper-responsiveness, and worse measurements
of FEV1/FVC and airways resistance/inflammation as well as
abnormally remodelled airways in comparison with subjects
with asthma with ND. Hyperpolarised 3He ventilation abnor-
malities were spatially and quantitatively related to remodelled
airways in subjects with asthma providing a better understanding
of the aetiology of heterogeneous ventilation abnormalities in
asthma and the clinical meaning of these abnormalities in sub-
jects with asthma with similar FEV1.
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